Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T12:16:10.072Z.
Calculation as of: 2026-10-06T12:16:10.072Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$83.96M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.70M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.75M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$81.22M
Price/FCF Ratio
N/A
TTM Avg
786.60
3Y Avg
786.60
5Y Avg
786.60
Market Cap
$87.86M
Price/FCF Ratio
N/A
TTM Avg
17.74
3Y Avg
16.00
5Y Avg
17.53
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $83.49M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | N/A | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $81.22M | N/A | 786.60 | 786.60 | 786.60 |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 4.00 | 5.32 | 4.50 | 8.18 |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | N/A | 17.74 | 16.00 | 17.53 |
| electroCore, Inc. (ECOR)vs › | $91.33M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $91.68M | N/A | 24.77 | 24.77 | 24.77 |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
